Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Thyroid Nodule 1Thyroid Neoplasms 1Sarcoma, Synovial 1Sarcoma 1Neurofibrosarcoma 1Malignant mesenchymal tumor 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Fibrosarcoma 1Chondrosarcoma, Extraskeletal Myxoid 1Carcinoma, Lobular 1COVID-19 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Cyclophosphamide 77Docetaxel 69Capecitabine 64Trastuzumab 61Paclitaxel 50Tamoxifen 47Epirubicin 47Letrozole 44pyrotinib 40Fulvestrant 37Doxorubicin 35Vinorelbine 33Radiotherapy 32Carboplatin 32Anastrozole 28exemestane 27Neoadjuvant Therapy 24Drug Therapy 22Fluorouracil 21palbociclib 20Exercise 20Chemotherapy, Adjuvant 19Bevacizumab 18pertuzumab 16Goserelin 16Cisplatin 16liposomal doxorubicin 15Mammography 14Gemcitabine 14Blood Specimen Collection 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Breast Neoplasms × Molecular Diagnostic Techniques × Clear all
NCT00536718 2013-08-12

Genetics of Women With Lobular Carcinoma in Situ of the Breast

National Cancer Institute (NCI)

Unknown
3,000 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡